Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2010
03/30/2010CA2162150C Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/30/2010CA2144223C Effector proteins of rapamycin
03/25/2010WO2010034018A2 Msp nanopores and related methods
03/25/2010WO2010033923A2 Genus-wide chlamydial peptide vaccine antigens
03/25/2010WO2010033922A2 Chimeric promoters and their uses in plants
03/25/2010WO2010033921A2 Photoautotrophic adipogenesis technology (phat)
03/25/2010WO2010033871A2 Compositions and methods targeting glutaminase
03/25/2010WO2010033825A2 Genetic variants associated with abdominal aortic aneurysms
03/25/2010WO2010033823A2 Methods and compositions for degrading pectin
03/25/2010WO2010033822A2 Therapeutic and diagnostic strategies
03/25/2010WO2010033818A2 Mirna targets
03/25/2010WO2010033798A2 Live bacterial vaccines resistant to carbon dioxide (co2), acidic ph and/or osmolarity for viral infection prophylaxis or treatment
03/25/2010WO2010033667A2 Wstf regulates the dna damage response of h2a.x via novel tyrosine kinase activity
03/25/2010WO2010033639A2 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
03/25/2010WO2010033580A2 Curcumin conjugates for treating and preventing cancers
03/25/2010WO2010033564A1 Transgenic plants having increased biomass
03/25/2010WO2010033553A2 Gene expression related to preeclampsia
03/25/2010WO2010033337A1 Rabies virus-based recombinant immunocontraceptive compositions and methods of use
03/25/2010WO2010033321A2 Novel bacillus thuringiensis gene with lepidopteran activity
03/25/2010WO2010033320A2 Novel bacillus thuringiensis gene with coleopteran activity
03/25/2010WO2010033319A2 Novel bacillus thuringiensis gene with lepidopteran activity
03/25/2010WO2010033248A2 Neutral nanotransporters
03/25/2010WO2010033247A2 Reduced size self-delivering rnai compounds
03/25/2010WO2010033246A1 Rna interference in skin indications
03/25/2010WO2010033237A2 Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules
03/25/2010WO2010033230A2 Use of fluorescent protien in cyanobacteria and algae for improving photosynthesis and preventing cell damage
03/25/2010WO2010033085A1 Chinese hamster ovary cell lines
03/25/2010WO2010032991A2 Primer and probe for enterovirus detection and method for detecting enterovirus using same
03/25/2010WO2010032816A1 Novel lysophosphatidylserine receptor
03/25/2010WO2010032797A1 Breast cancer metastasis determination method and blood serum evaluation method
03/25/2010WO2010032786A1 Transgenic animal
03/25/2010WO2010032762A1 Production and use of yeast having increased cellulose hydrolysis ability
03/25/2010WO2010032704A1 Pharmaceutical preparation comprising micro-rna-143 derivative
03/25/2010WO2010032698A1 Method for producing lactic acid from plant-derived raw material, and lactic-acid-producing bacterium
03/25/2010WO2010032697A1 Bacterium capable of producing lactic acid, and method for producing lactic acid
03/25/2010WO2010032696A1 Diagnosis method and therapeutic method for cancer
03/25/2010WO2010032595A1 Process for simultaneously producing large quantity of various molecular or particle clusters having any distribution profile and distribution density and mask material for use in the process
03/25/2010WO2010032506A1 Nucleic acid drug for treating allergic disease
03/25/2010WO2010032492A1 Koji mold alkaline protease promoter
03/25/2010WO2010032230A1 Non-auxotrophic selection marker
03/25/2010WO2010031918A1 Importation of a ribozyme into vegetable mitochondria by a pseudo-trna that can be aminoacylated by valine
03/25/2010WO2010031875A1 Drug metabolism
03/25/2010WO2010031865A1 Identification and characterisation of recombinant viral gene therapy vectors
03/25/2010WO2010031837A1 Viral strains derived from the vaccinia virus lister vacv-107 and uses thereof
03/25/2010WO2010031828A1 Tyrosine kinase receptor tyro3 as a therapeutic target in the treatment of cancer
03/25/2010WO2010031772A2 Alternative butanol production process in a microbial cell
03/25/2010WO2010031312A1 Regulation of nitrogen starvation response
03/25/2010WO2010031168A1 HETERO-MULTIVALENT BINDING AGENTS FOR MEMBERS OF THE TGFβ SUPERFAMILY
03/25/2010WO2010031101A1 Method for the production of an additive for the enzymatic decomposition of mycotoxins, additive, and use thereof
03/25/2010WO2010031100A1 Method for the production of a feed additive for the oxygen-independent, enzymatic decomposition of mycotoxins, feed additive, and use thereof
03/25/2010WO2010016760A3 Immunogenic composition for the treatment of e. faecium infection
03/25/2010WO2010015899A3 Novel method to generate meganucleases with altered characteristics
03/25/2010WO2010013071A3 Methods concerning ppar delta and antagonists thereof
03/25/2010WO2010009465A3 Htlv-ii vector and methods of use
03/25/2010WO2010009404A3 Markers associated with soybean rust resistance and methods of use therefor
03/25/2010WO2010008809A3 Compositions and methods for early stage sex determination
03/25/2010WO2010006454A3 Functionalized polypeptides
03/25/2010WO2010006239A3 Regulation of apoptosis by neural specific splice variants of ig20
03/25/2010WO2010005273A3 Transgenic zebrafish and method for mass production of human lactoferrin using the same
03/25/2010WO2009158139A3 Engineering of xylose reductase and overexpression of xylitol dehydrogenase and xylulokinase improves xylose alcoholic fermentation in the thermotolerant yeast hansenula polymorpha
03/25/2010WO2009156853A3 Compounds, compositions, and methods useful for modulating the expression of histone deacetylase (hdac) gene expression and/or activity
03/25/2010WO2009156405A8 Novel immunoadjuvant flagellin-based compounds and use thereof
03/25/2010WO2009155060A3 Anti-pyk2 antibodies
03/25/2010WO2009152364A3 Proteins that fluoresce at infrared wavelengths or generates singlet oxygen upon illumination
03/25/2010WO2009150550A9 Genetic component of complications in type 2 diabetes
03/25/2010WO2009150215A3 Hybrid proteins comprising membrane receptor and ion channel, and their use as biosensors
03/25/2010WO2009149395A3 Variant alpha-amylases from bacillus subtilis and methods of use, thereof
03/25/2010WO2009141729A3 Anti-tumoral cells
03/25/2010WO2009139630A3 Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
03/25/2010WO2009137577A3 Leishmania vaccine using sand fly salivary immunogen
03/25/2010WO2009137146A3 Method for producing continuous cell lines
03/25/2010WO2009136382A3 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
03/25/2010WO2009133098A3 β-LACTAM PRODUCING STRAINS
03/25/2010WO2009129247A3 Sequence diversity generation in immunoglobulins
03/25/2010WO2009088256A8 Baculovirus-based vaccines
03/25/2010WO2008078835A9 Method for determination of dna methylation
03/25/2010WO2008078834A9 Method for determination of dna methylation
03/25/2010WO2006076423A8 Genes and uses for plant improvement
03/25/2010US20100077511 Caffeine fraction obtained from tea leaves and a method for inducing agrobacterium tumefaciens-mediated genetic transformation in plants using said caffeine fraction
03/25/2010US20100077510 Plant galactinol synthase homologs
03/25/2010US20100077509 Nucleic acid molecules encoding plant proteins in the c3hc4 family and methods for the alteration of plant cellulose and lignin content
03/25/2010US20100077508 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
03/25/2010US20100077507 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
03/25/2010US20100077506 Peroxidase Gene Nematode Inducible Promotors and Methods of Use
03/25/2010US20100077505 Auxin Transport Proteins
03/25/2010US20100077504 Temporal seed promoters for expressing genes in plants
03/25/2010US20100077503 Transferases, Epimerases, Polynucleotides Encoding These and Uses Thereof
03/25/2010US20100077499 Cybrid Plant of the Genus Lactuca and Method for Producing the Same
03/25/2010US20100077497 Ip-10 antibodies and their uses
03/25/2010US20100077496 MO-1, A Gene Associated With Morbid Obesity
03/25/2010US20100077495 Compositions and methods for the expression of nucleic acids
03/25/2010US20100077494 Ungulates with Genetically Modified Immune Systems
03/25/2010US20100077491 Modulators of RNF5 and Uses Thereof
03/25/2010US20100077490 Animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
03/25/2010US20100076179 Antibodies to mammalian cytokine-like factor 7
03/25/2010US20100076177 Hybrid antibodies
03/25/2010US20100076176 Sweetener Preparations and Methods of Use
03/25/2010US20100076054 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
03/25/2010US20100076053 Sequence of dsrna: atn-rna, intervention using irnai, use of a sequence of dsrna: atn-rna, a method of treating and inhibiting a brain tumor, a kit for inhibiting cancer cell which expresses tenascin, a method for a kit preparation in a brain tumor therapy